CMPS

COMPASS Pathways plc

There isn't enough reported data to score CMPS yet.

CMPS Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

CMPS's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

CMPS PE Valuation

CMPS has no meaningful PE right now: it lost money over the past year.

CMPS Forward outlook

MetricOutlook
--
Losses growing
--
--
Limited
Low

Analysts expect CMPS's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.

CMPS Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $9.12 on Nov 12.

There is not enough scenario data to assess CMPS's risk to reward.

CMPS Earnings Per Share

Q4 2023: $-2.32Q1 2024: $-2.30Q4 2025: $-3.08Q1 2026: $-3.14Q2 2026: $-4.61
Q4 2023: $-2.32Q1 2024: $-2.30Q4 2025: $-3.08Q1 2026: $-3.14Q2 2026: $-4.61
QuarterTTM EPSYoY
Q1 2024-$2.30-$0.07
Q4 2023-$2.32-$0.16
Q3 2023-$2.59-$0.55
Q2 2023-$2.35-$0.36
Q1 2023-$2.23-$0.30
Q4 2022-$2.16-$0.38
Q3 2022-$2.04-$0.34
Q2 2022-$1.99-$0.20

CMPS lost $4.61 per share over the past year, and its loss has widened in each of the last three quarters.

CMPS Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

CMPS's revenue is shrinking: $0 last quarter.

CMPS Free Cash Flow

Q4 2023: −$28MQ1 2024: −$21MQ2 2024: −$34MQ3 2024: −$22MQ4 2024: −$42MQ1 2025: −$46MQ2 2025: −$39MQ3 2025: −$35MQ4 2025: −$38MQ1 2026: −$48MQ2 2026: −$40MQ3 2026: −$51M
Q4 2023: −$28MQ1 2024: −$21MQ2 2024: −$34MQ3 2024: −$22MQ4 2024: −$42MQ1 2025: −$46MQ2 2025: −$39MQ3 2025: −$35MQ4 2025: −$38MQ1 2026: −$48MQ2 2026: −$40MQ3 2026: −$51M
QuarterFree cash flowYoY
Q3 2026-$50.8M-$15.7M
Q2 2026-$40.3M-$1.6M
Q1 2026-$47.9M-$2.3M
Q4 2025-$37.8M+$4M
Q3 2025-$35.1M-$12.9M
Q2 2025-$38.7M-$4.3M
Q1 2025-$45.7M-$24.8M
Q4 2024-$41.8M-$14M

CMPS has burned cash in almost every quarter: −$177M over the past year, against −$161M the year before.

CMPS Total Shares

Q1 2024: 64MQ2 2024: 68MQ3 2024: 68MQ1 2025: 99MQ2 2025: 93MQ3 2025: 95MQ1 2026: 130MQ2 2026: 135M
Q1 2024: 64MQ2 2024: 68MQ3 2024: 68MQ1 2025: 99MQ2 2025: 93MQ3 2025: 95MQ1 2026: 130MQ2 2026: 135M
PeriodChange %Net change
Quarterly+3.7%+4.8M shares
1 year+37%+36.4M shares
3 years+218%+92.5M shares
5 years+276%+99.1M shares

CMPS has 135M diluted shares, up 37% from a year ago.

CMPS Net Leverage

CMPS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CMPS Weekly Momentum

MetricValueStatus
RSI41.0Neutral
Stochastic16.8Oversold

CMPS's weekly RSI is 41 (neutral) and its Stochastic is 17 (oversold).

CMPS PE vs Healthcare Sector

CMPS has no meaningful PE right now: it lost money over the past year.

CMPS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$11.017% below
20 week MA$12.426% below
50 week MA$9.847.3% below
100 week MA$7.1128% above
200 week MA$7.5022% above

CMPS has slipped below its 8-, 20- and 50-week averages, though it's still 22% above its 200-week average.

CMPS Yearly ROI

YearStart priceEnd priceROI
2020$29.0$55.0+90%
2021$55.0$23.8-57%
2022$23.8$8.45-64%
2023$8.45$8.75+3.6%
2024$8.75$3.99-54%
2025$3.99$6.68+67%
2026 YTD$6.68$9.12+37%

CMPS is up 37% so far in 2026, after finishing lower in three of the previous six years.

Give your agent the market.

Get API key